AI Bias Analysis
4 models · Takes ~15 seconds
The French pharma firm Servier is buying an experimental muscular dystrophy drug from Edgewise Therapeutics for $1.55 billion upfront.
Source
Stat News
Opens original article in a new tab
The Trump administration disregards infectious disease playbook, CEPI offers vaccine funding, and other health news from Morning Rounds
Two years after General Catalyst said it was buying Ohio safety-net hospital Summa Health, executives shed light on how the “transformation” is going.
The arbitration process has protected patients but generated financial windfalls for some clinicians.
A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using peptides.
